BBH (BBH) Stock Price & Analysis
BBH (BBH) rose 0.12% to USD 203.57 as of July 25, 2026 at 14:23 UTC, according to Nexqual real-time market data.
BBH last closed at USD 203.33; the session ranged USD 203.57–205.17 on volume of 2,058 shares. Market capitalization is —, with a 52-week range of USD 156.45–212.54 (NGM). Source: Nexqual, July 25, 2026 at 14:23 UTC.
Key Statistics (as of July 25, 2026 at 14:23 UTC)
| Price | USD 203.57 |
|---|---|
| Change | ▲ 0.12% (up) |
| Previous Close | USD 203.33 |
| Open | USD 205.09 |
| Day Range | USD 203.57 – 205.17 |
| 52-Week Range | USD 156.45 – 212.54 |
| Volume | 2,058 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (BBH)
Nexqual's technical model rates BBH "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 14:23 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 54.9 (neutral) |
| vs SMA50 | Above (USD 194.16) |
| MACD | 2.39 (positive) |
Financial Health Score (BBH)
Nexqual rates BBH's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 14:23 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PPH | VanEck Pharmaceutical ETF | USD 110.63 | ▲ 1.85% |
| HHH | Howard Hughes Holdings Inc. | USD 65.91 | ▼ 0.84% |
| RTH | VanEck Retail ETF | USD 255.47 | ▼ 0.62% |
| PBE | Invesco Biotechnology & Genome | USD 89.59 | ▲ 0.28% |
| FBT | First Trust Amex Biotech Index | USD 247.39 | ▲ 0.9% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 14:23 UTC. This page is informational and not investment advice.